Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
Precision Medicine and Pharmacogenomics
Precision medicine is reshaping clinical research by integrating genetic, molecular, and biochemical data to refine drug development and patient stratification.
Seriant’s specialized laboratory infrastructure supports clinical trials by leveraging advanced biomarker strategies, metabolomics, proteomics, and pharmacogenomics to optimize study outcomes and improve therapeutic targeting.
Our expertise in these fields, combined with our laboratory infrastructure, supports your clinical study and drives advancements in precision medicine.
Pharmacogenomics examines the genetic variations that influence drug metabolism and response. By incorporating pharmacogenomic insights into clinical trials, we help optimize dosing strategies, reduce variability in treatment response, and enhance patient selection criteria.
Metabolomics analyzes small molecules (metabolites) that reflect biochemical processes. This enables precise patient stratification, optimized dosing strategies, and deeper insights into therapeutic responses, supporting more efficient and targeted clinical trial.
Proteomics examines the complete set of proteins within a cell or organism to identify disease-specific proteins and drug targets. In clinical research, it supports biomarker discovery, patient stratification, and the development of targeted therapies.
Biomarkers provide measurable biological indicators that support patient stratification, treatment response assessment, and endpoint validation in clinical trials. Their use enhances study design, accelerates regulatory approval, and optimizes investigational product development.
Our specialty services are seamlessly embedded into end-to-end project management, ensuring a streamlined and efficient clinical trial process from startup to closeout. We provide comprehensive support across regulatory strategies, site training, supply chain management, monitoring, data deliveries, statistical analysis, and final trial closeout, creating a fully integrated approach that minimizes risk and maximizes efficiency.
Interested in this service?
Let’s work together!
